Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-26 5:26 pm Purchase | 2023-12-31 | 13G | HAVARD BIOSCIENCE INC HBIO | BlackRock Inc. BLK | 291,381 6.800% | 170,469 (+140.99%) | Filing History |
| 2024-01-22 10:55 am Sale | 2024-01-16 | 13G | HAVARD BIOSCIENCE INC HBIO | Leviticus Partners LP | 210,667 4.940% | -5,212 (-2.41%) | Filing History |
| 2023-08-28 3:07 pm Purchase | 2023-08-25 | 13G | HAVARD BIOSCIENCE INC HBIO | Leviticus Partners LP | 215,879 5.060% | 10,488 (+5.11%) | Filing History |
| 2023-02-16 3:11 pm Unchanged | 2022-12-31 | 13G | HAVARD BIOSCIENCE INC HBIO | 272 Capital LP | 326,480 7.800% | 0 (Unchanged) | Filing History |
| 2023-02-15 5:30 pm Purchase | 2022-11-29 | 13G | HAVARD BIOSCIENCE INC HBIO | 272 Capital LP | 326,480 7.840% | 326,480 (New Position) | Filing History |
| 2023-02-14 4:05 pm Purchase | 2022-12-31 | 13G | HAVARD BIOSCIENCE INC HBIO | Harvey Partners LLC | 291,150 7.000% | 291,150 (New Position) | Filing History |
| 2023-02-13 5:12 pm Purchase | 2022-12-31 | 13G | HAVARD BIOSCIENCE INC HBIO | PUNCH & ASSOCIATES INVESTMENT MANAGEMENT INC. | 276,404 6.640% | 59,726 (+27.56%) | Filing History |
| 2023-02-13 3:55 pm Sale | 2022-12-31 | 13G | HAVARD BIOSCIENCE INC HBIO | Portolan Capital Management LLC | 105,430 2.530% | -148,450 (-58.47%) | Filing History |
| 2023-01-11 1:30 pm Sale | 2023-01-06 | 13G | HAVARD BIOSCIENCE INC HBIO | Leviticus Partners LP | 205,391 4.930% | -20,000 (-8.87%) | Filing History |
| 2022-12-21 4:20 pm Purchase | 2022-12-16 | 13G | HAVARD BIOSCIENCE INC HBIO | Leviticus Partners LP | 225,391 5.410% | 225,391 (New Position) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | HAVARD BIOSCIENCE INC HBIO | BlackRock Inc. BLK | 120,912 2.900% | -185,407 (-60.53%) | Filing History |
| 2022-06-21 4:01 pm Purchase | 2022-06-10 | 13G | HARVARD APPARATUS REGENERATIVE HRGN | HARVARD BIOSCIENCE INC HBIO | 708,516 5.800% | 708,516 (New Position) | Filing History |
| 2022-02-14 11:02 am Purchase | 2021-12-31 | 13G | HAVARD BIOSCIENCE INC HBIO | PUNCH & ASSOCIATES INVESTMENT MANAGEMENT INC. | 216,678 5.310% | 216,678 (New Position) | Filing History |
| 2022-02-11 2:01 pm Purchase | 2021-12-31 | 13G | HAVARD BIOSCIENCE INC HBIO | Portolan Capital Management LLC | 253,880 6.220% | 47,315 (+22.91%) | Filing History |
| 2022-02-08 3:52 pm Sale | 2022-02-14 | 13G | HAVARD BIOSCIENCE INC HBIO | DIMENSIONAL FUND ADVISORS LP | 188,360 4.600% | -14,339 (-7.07%) | Filing History |
| 2022-02-02 7:11 pm Purchase | 2021-12-31 | 13G | HAVARD BIOSCIENCE INC HBIO | BlackRock Inc. BLK | 306,319 7.500% | 10,928 (+3.70%) | Filing History |
| 2021-09-03 2:37 pm Purchase | 2021-08-24 | 13G | HAVARD BIOSCIENCE INC HBIO | Portolan Capital Management LLC | 206,565 5.070% | 206,565 (New Position) | Filing History |